Overweight and obesity.
Conditions
Interventions
Intervention 1: Intervention group:Reality Therapy according to the protocol specified by Psychologist for 8 sessions in the first three weeks of study combined with Low calorie diet that reduced 500
Sponsors
Medical University of Yazd
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: age between 18 to 65 body mass index between 25 to 35 individuals don't use drugs that increasing apetite individual hasn't use drug or supplement for two month ago individual hasn't do bariatric surgery individual has not been pregnancy or lactation He/She had dichotomous thinking He/She had body image disorder
Exclusion criteria
Exclusion criteria: depression disorder personality disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dichotomous Thinking Scale in Dichotomous Thinking Questionnaire. Timepoint: "Measuring Dichotomous thinking at the beginning of the study (before the intervention) and at the end of the reality therapy intervention". Method of measurement: Dichotomous Thinking Questionnaire.;Body Image Scale in Body Image Concern Inventory Questionnaire. Timepoint: "Measuring Body Image Concern Inventory at the beginning of the study (before the intervention) and at the end of the reality therapy intervention". Method of measurement: Body Image Concern Inventory Questionnaire.;Individuals body weight. Timepoint: measuring of body weight in 1, 4, 11 weeks. Method of measurement: By using inbody device. | — |
Secondary
| Measure | Time frame |
|---|---|
| High-density lipoprotein. Timepoint: High-density lipoprotein levels were measured before and after the study. Method of measurement: outoanalyzer bt3000.;Low-density lipoprotein. Timepoint: low-density lipoprotein levels were measured before and after the study. Method of measurement: outoanalyzer bt3000.;Cholesterol. Timepoint: cholesterol levels were measured before and after the study. Method of measurement: outoanalyzer bt3000.;Triglyceride. Timepoint: triglyceride levels were measured before and after the study. Method of measurement: outoanalyzer bt3000.;High-sensitivity C-reactive protein. Timepoint: high-sensitivity C-reactive protein levels were measured before and after the study. Method of measurement: outoanalyzer bt3000.;Fasting blood sugar. Timepoint: fasting blood sugar levels were measured before and after the study. Method of measurement: outoanalyzer bt3000.;Complete blood count. Timepoint: Complete blood count levels were measured before and after the study. Method of measurement: Using approved kits and cell counter.;Aspartate Aminotransferase. Timepoint: Aspartate Aminotransferase levels were measured before and after the study. Method of measurement: outoanalyzer bt3000.;Alanin Aminotransferase. Timepoint: Alanin Aminotransferase levels were measured before and after the study. Method of measurement: outoanalyzer bt3000.;Hip circumference. Timepoint: hip circumference were measured before, middle and after the study. Method of measurement: By using inbody device.;Abdomen circumference. Timepoint: abdomen circumference were measured before, middle and after the study. Method of measurement: By using inbody device.;Body fat mass. Timepoint: body fat mass were measured before, middle and after the study. Method of measurement: By using inbody device.;Free fat mass. Timepoint: free fat mass were measured before, middle and after the study. Method of measurement: By using inbody device.;Body mass index. Timepoint: body mass index were measured befo | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Hassan Mozaffari Khosravi
Medical University of Yazd
Outcome results
None listed